Literature DB >> 9179271

Radiation biology in brachytherapy.

D J Brenner1.   

Abstract

The biological rationale for the use of brachytherapy, which is undergoing a significant resurgence in the United States, is reviewed with emphasis on low dose rate (LDR brachytherapy). Some of the newer alternatives that have recently been developed, such as pulsed dose rate (PDR) brachytherapy, are discussed.

Entities:  

Mesh：

Year:  1997        PMID： 9179271     DOI： 10.1002/(sici)1096-9098(199705)65:1<66::aid-jso13>3.0.co;2-q

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  4 in total

1.  The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.

Authors:  A Danielsson; E Karlsson; U Delle; K Helou; C Mercke
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-18       Impact factor: 4.553

2.  Human Lung Cancer Risks from Radon - Part III - Evidence of Influence of Combined Bystander and Adaptive Response Effects on Radon Case-Control Studies - A Microdose Analysis.

Authors:  Bobby E Leonard; Richard E Thompson; Georgia C Beecher
Journal:  Dose Response       Date:  2010-09-10       Impact factor: 2.658

3.  Hyperfractionation of HDR brachytherapy - influence on doses and biologically equivalent doses in clinical target volume and healthy tissues.

Authors:  Janusz Skowronek; Grzegorz Zwierzchowski; Tomasz Piotrowski
Journal:  J Contemp Brachytherapy       Date:  2009-07-17

4.  Influence of length of interval between pulses in PDR brachytherapy (PDRBT) on value of Biologically Equivalent Dose (BED) in healthy tissues.

Authors:  Janusz Skowronek; Julian Malicki; Grzegorz Zwierzchowski; Tomasz Piotrowski
Journal:  J Contemp Brachytherapy       Date:  2010-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.